Recent CELC News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2026 08:58:24 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/20/2026 11:30:22 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/18/2026 08:55:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/18/2026 08:05:38 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/15/2026 12:12:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 09:15:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 08:05:21 PM
- Celcuity Inc. Reports Release of First Quarter 2026 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/14/2026 08:01:00 PM
- Celcuity’s Phase 3 VIKTORIA-2 Trial of Gedatolisib as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer Expanding to Include Endocrine-Sensitive Patients • GlobeNewswire Inc. • 05/14/2026 11:30:00 AM
- Celcuity Schedules Release of First Quarter 2026 Financial Results and Webcast/Conference Call • GlobeNewswire Inc. • 05/07/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:30:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/04/2026 09:39:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 09:10:31 PM
- Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort • GlobeNewswire Inc. • 05/01/2026 09:03:22 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/02/2026 08:40:20 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/02/2026 08:35:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/02/2026 08:30:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:05:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/31/2026 08:38:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 11:30:43 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:10:32 PM
- Celcuity Inc. Reports Release of Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/25/2026 08:01:00 PM
- Celcuity Schedules Release of Fourth Quarter and Full Year 2025 Financial Results and Webcast/Conference Call • GlobeNewswire Inc. • 03/18/2026 12:00:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 03/09/2026 11:17:15 PM
- Celcuity Announces Publication of Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Study of Gedatolisib Regimens in HR+/HER2- Advanced Breast Cancer in Journal of Clinical Oncology • GlobeNewswire Inc. • 03/09/2026 09:42:40 PM

